Stockreport

Larimar Therapeutics price target raised to $12 from $11 at Wedbush [Yahoo! Finance]

Larimar Therapeutics, Inc.  (LRMR) 
PDF The firm notes that last week, the company completed an upsized $100M offering following receipt of Breakthrough Therapy designation for nomlabofusp in Friedreich's atax [Read more]